Aura Biosciences AURA
$6.87 −$0.11 (-1.58%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.77 -1.46%
Open$6.51
Prev close$6.98
Day range$6.51 – $6.98
Volume791.1K
Market cap$714.99M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$35.06M-25.6% YoY
Net profit-$32.07M-22.7% YoY
Diluted EPS-$0.29+27.5% YoY
Free cash flow-$26.52M-31.4% YoY
Operating cash flow-$26.44M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-61.7%
Return on assets-53.5%
Return on invested capital-59.3%
Current ratio14.21
Liabilities / assets10.6%
Cash & investments$297.23M
Total debt$12.85M
Net cash (debt)$284.38M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $35.06M | $48.07M | $34.87M | $112.79M | $27.24M |
| Selling and Admin Expenses | $10.32M | $17.32M | $6.91M | $22.49M | $5.34M |
| -General & Admin Expense | $10.32M | $17.32M | $6.91M | $22.49M | $5.34M |
| Research & Development | $24.74M | $30.75M | $27.96M | $90.30M | $21.90M |
| Operating Profit | -$35.06M | -$48.07M | -$34.87M | -$112.79M | -$27.24M |
| Net Non-Operating Interest Income (Expense) | $3.02M | $2.31M | $1.19M | $6.63M | $1.54M |
| Non-Operating Interest Income | $3.02M | $2.31M | $1.19M | $6.63M | $1.54M |
| Other Income (Expense) | $17,000.00 | $154,000.00 | $2,000.00 | $77,000.00 | $149,000.00 |
| Other Non-Operating Income (Expenses) | $17,000.00 | $154,000.00 | $2,000.00 | $77,000.00 | $149,000.00 |
| Pretax Profit | -$32.03M | -$45.61M | -$33.67M | -$106.08M | -$25.54M |
| Tax | $38,000.00 | $29,000.00 | $11,000.00 | $108,000.00 | $15,000.00 |
| Net Profit | -$32.07M | -$45.64M | -$33.69M | -$106.19M | -$25.56M |
| Profit from Continuing Operations | -$32.07M | -$45.64M | -$33.69M | -$106.19M | -$25.56M |
| Net Income to Parent Company | -$32.07M | -$45.64M | -$33.69M | -$106.19M | -$25.56M |
| Net Income to Common Stockholders | -$32.07M | -$45.64M | -$33.69M | -$106.19M | -$25.56M |
| Basic EPS | -$0.29 | -$0.48 | -$0.50 | -$1.76 | -$0.37 |
| Diluted EPS | -$0.29 | -$0.48 | -$0.50 | -$1.76 | -$0.37 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $321.62M | $348.13M | $137.68M | $169.43M | $169.43M |
| Total Current Assets | $303.10M | $329.03M | $118.50M | $149.74M | $149.74M |
| Cash and Cash Equivalents & Short-Term Investments | $297.23M | $323.84M | $114.73M | $144.24M | $144.24M |
| -Cash and Cash Equivalents | $41.67M | $67.84M | $84.79M | $59.52M | $59.52M |
| -Short Term Investments | $255.56M | $256.00M | $29.94M | $84.73M | $84.73M |
| Receivables | $1.87M | $1.76M | – | – | – |
| -Accrued Interest Receivable | $1.87M | $1.76M | – | – | – |
| Prepaid Assets | $3.14M | $2.61M | $2.71M | $4.32M | $4.32M |
| Other Current Assets | $851,000.00 | $819,000.00 | $1.06M | $1.18M | $1.18M |
| Total Non-Current Assets | $18.52M | $19.10M | $19.17M | $19.69M | $19.69M |
| Net PPE | $16.58M | $17.19M | $17.89M | $18.45M | $18.45M |
| -Gross PPE | $24.40M | $24.77M | $25.21M | $25.50M | $25.50M |
| -Accumulated Depreciation | -$7.82M | -$7.57M | -$7.33M | -$7.05M | -$7.05M |
| Other Non-Current Assets | $1.94M | $1.91M | $1.29M | $1.24M | $1.24M |
| Total Liabilities | $34.19M | $32.86M | $30.43M | $32.52M | $32.52M |
| Total Current Liabilities | $21.34M | $19.56M | $16.71M | $18.38M | $18.38M |
| Payables | $1.72M | $2.25M | $2.57M | $1.55M | $1.55M |
| -Accounts Payable | $1.72M | $2.25M | $2.57M | $1.55M | $1.55M |
| Current Accrued Expenses | $8.31M | $8.50M | $7.90M | $7.34M | $7.34M |
| Short-Term Debt and Capital Lease Obligation | $3.32M | $3.29M | $3.27M | $3.24M | $3.24M |
| -Current Capital Lease Obligation | $3.32M | $3.29M | $3.27M | $3.24M | $3.24M |
| Other Current Liabilities | $146,000.00 | $908,000.00 | $378,000.00 | $242,000.00 | $242,000.00 |
| Total Non-Current Liabilities | $12.85M | $13.30M | $13.72M | $14.13M | $14.13M |
| Long Term Debt and Capital Lease Obligation | $12.85M | $13.30M | $13.72M | $14.13M | $14.13M |
| -Long Term Capital Lease Obligation | $12.85M | $13.30M | $13.72M | $14.13M | $14.13M |
| Total Equity | $287.43M | $315.27M | $107.25M | $136.91M | $136.91M |
| Stockholders' Equity | $287.43M | $315.27M | $107.25M | $136.91M | $136.91M |
| Capital Stock | $1,000.00 | $1,000.00 | $0.00 | $0.00 | $0.00 |
| -Common Stock | $1,000.00 | $1,000.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $919.90M | $914.77M | $621.56M | $617.43M | $617.43M |
| Retained Earnings | -$591.81M | -$559.74M | -$514.10M | -$480.42M | -$480.42M |
| Less: Treasury Stock | -$39.09M | -$39.09M | – | – | – |
| Gains/Losses Not Affecting Retained Earnings | -$1.57M | -$670,000.00 | -$207,000.00 | -$102,000.00 | -$102,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$26.44M | -$32.50M | -$29.89M | -$84.74M | -$20.47M |
| Net cash flow from continuing operations | -$26.44M | -$32.50M | -$29.89M | -$84.74M | -$20.47M |
| Net Income from Continuing Operations | -$32.07M | -$45.64M | -$33.69M | -$106.19M | -$25.56M |
| Depreciation & Depletion & Amortization | $251,000.00 | $260,000.00 | $274,000.00 | $1.13M | $272,000.00 |
| Other Non-Cash Items | $432,000.00 | $442,000.00 | $412,000.00 | $1.58M | $402,000.00 |
| Change in Working Capital | $630,000.00 | $406,000.00 | -$426,000.00 | $5.97M | $1.56M |
| -Change in Prepaid Assets | -$677,000.00 | -$1.42M | $1.73M | $4.03M | $2.68M |
| -Change in Payables and Accrued Expense | $1.76M | $2.84M | -$1.72M | $3.29M | -$554,000.00 |
| -Change in Other Current Assets | -$28,000.00 | -$622,000.00 | -$46,000.00 | $47,000.00 | -$194,000.00 |
| -Change in Other Current Liabilities | -$425,000.00 | -$397,000.00 | -$386,000.00 | -$1.39M | -$377,000.00 |
| Net cash flow from investing | $114,000.00 | -$226.04M | $54.90M | $35.60M | $29.82M |
| Net Cash Flow from Continuing Investing Activities | $114,000.00 | -$226.04M | $54.90M | $35.60M | $29.82M |
| Net PPE Purchase and Sale | -$80,000.00 | -$21,000.00 | -$102,000.00 | -$447,000.00 | -$176,000.00 |
| Net Investment Purchase and Sale | $194,000.00 | -$226.01M | $55.00M | $36.04M | $30.00M |
| Financing Cash Flow | $206,000.00 | $241.75M | $300,000.00 | $77.16M | $2.77M |
| Net Cash Flow from Continuing Financing Activities | $206,000.00 | $241.75M | $300,000.00 | $77.16M | $2.77M |
| Net Common Stock Issuance | -$123,000.00 | – | – | $52.57M | $2.77M |
| Proceeds from Stock Option Exercised | $329,000.00 | $21.34M | $300,000.00 | $24.58M | $0.00 |
| Ending Cash Balance | $42.44M | $68.60M | $85.56M | $60.28M | $60.28M |
| Net Change in Cash | -$26.12M | -$16.78M | $25.31M | $28.01M | $12.12M |
| Beginning Cash Balance | $68.60M | $85.56M | $60.28M | $32.46M | $48.32M |
| Effect of Exchange Rate Changes | -$47,000.00 | -$173,000.00 | -$27,000.00 | -$186,000.00 | -$160,000.00 |
| Free Cash Flow | -$26.52M | -$32.52M | -$30.00M | -$85.19M | -$20.65M |
No comments yet — be the first to weigh in on AURA.
Sign in to join the discussion.